AICAR.

AICAR is a AMP-kinase activator and nucleoside analog. With the molecular formula C₉H₁₄N₄O₅ and a molecular weight of 258.24 g/mol (CAS: 2627-69-2), it is characterized in foundational biochemical res...

$57.00

Lab Verified

Clinical Grade

PMID Cited

Mechanism of Action.

Published preclinical research has characterized the following molecular pathways and receptor interactions for AICAR.

Receptor interaction

AMP-activated protein kinase (AMPK)

Published research demonstrates AICAR modulates targeted signaling cascades within cell tissue models.

Signaling cascade

Metabolic pathways

In cellular environments, AICAR exhibits selective binding and corresponding pathway activation.

Evidence Based

Clinical Literature

View All Studies

Preclinical

Research review on AICAR molecular characterization.

Preclinical studies have characterized the molecular properties and receptor binding profiles of AICAR in standardized assay systems.

Preclinical

AICAR structure-activity relationship analysis.

Structure-activity relationship studies have examined the functional domains and binding characteristics of AICAR in cell-free and cell-based systems.

RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.

Continue Exploring